Jeffrey Bunn, MD
Plastic Surgery within the Head & Neck · Spokane, WANPI 1760432868
Payments from drug & device makers
What this record shows
Inspire Medical Systems, Inc. accounts for 67.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,164 and has fallen 85.6% since, to $168 in 2025. That places this record below the midpoint for plastic surgery within the head & neck clinicians in WA, where the typical reported total is $2,309.
Across 11 payments — averaging $154.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Stryker$168
- AstraZeneca$125
- Polynovo North America LLC$98
- Ascendis Pharma Endocrinology Inc$78
- Exelixis Inc.$32
- plus $56 from 3 others
What the payments were for
- Travel & lodging$98958%
- Food & beverage$71542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 2 | $1,148 |
| Stryker | 2 | $168 |
| AstraZeneca | 1 | $125 |
| Polynovo North America LLC | 1 | $98 |
| Ascendis Pharma Endocrinology Inc | 1 | $78 |
| Exelixis Inc. | 1 | $32 |
| GSK | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Sanofi | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,704 in reported general payments places this provider in the 30th percentile of 21 plastic surgery within the head & neck providers in Washington.
See all plastic surgery within the head & neck providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $441 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $165 |
| Omeprazole | 13 | $120 |
| Chlorhexidine Gluconate | 11 | $84 |
| Oxycodone Hcl | 12 | $54 |
| Tramadol Hcl | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in Spokane
- Michael CruzSpokane$25K
- Neal FutranSeattle$40K
- Kristen MoeSeattle$16K
- Scott BevansTacoma$9K
- Joseph BellairsFederal Way$8K
- Wayne LarrabeeSeattle$4K
- Seth SchwartzSeattle$4K
- Justin PavlovichTacoma$4K
- Nigel DenisBurien$3K
- Brittany BarberSeattle$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.